References
[1]. Erickson G, Dobson NR, Hunt CE: Immature control of breathing and apnea of prematurity: the known and unknown .Journal of perinatology : official journal of the California Perinatal Association 2021, 41 (9):2111-2123.
[2]. Montenegro BL, Amberson M, Veit L, Freiberger C, Dukhovny D, Rhein LM: Economics of Home Monitoring for Apnea in Late Preterm Infants . Respiratory care 2017, 62 (1):42-48.
[3]. Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM:Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity . Paediatric drugs 2014,16 (2):169-177.
[4]. Alhersh E, Abushanab D, Al-Shaibi S, Al-Badriyeh D:Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses . Paediatric drugs 2020, 22 (4):399-408.
[5]. Pergolizzi J, Kraus A, Magnusson P, Breve F, Mitchell K, Raffa R, LeQuang JAK, Varrassi G: Treating Apnea of Prematurity .Cureus 2022, 14 (1):e21783.
[6]. Henderson-Smart DJ, De Paoli AG: Prophylactic methylxanthine for prevention of apnoea in preterm infants . The Cochrane database of systematic reviews 2010,2010 (12):Cd000432.
[7]. Nylander Vujovic S, Nava C, Johansson M, Bruschettini M:Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review . Pediatric research 2020,88 (3):357-364.
[8]. Kua KP, Lee SW: Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates .Br J Clin Pharmacol 2017, 83 (1):180-191.
[9]. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al :The PRISMA 2020 statement: an updated guideline for reporting systematic reviews . BMJ (Clinical research ed) 2021,372 :n71.
[10]. Amaro CM, Bello JA, Jain D, Ramnath A, D’Ugard C, Vanbuskirk S, Bancalari E, Claure N: Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants: A Randomized, Placebo-Controlled Trial . The Journal of pediatrics 2018,196 :52-57.
[11]. Armanian AM, Iranpour R, Faghihian E, Salehimehr N:Caffeine Administration to Prevent Apnea in Very Premature Infants . Pediatrics and neonatology 2016,57 (5):408-412.
[12]. Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, Sinha S, Tin W: Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups . The Journal of pediatrics 2010,156 (3):382-387.
[13]. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W: Caffeine therapy for apnea of prematurity . The New England journal of medicine 2006,354 (20):2112-2121.
[14]. Elmowafi M, Mohsen N, Nour I, Nasef N: Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial . The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2021:1-9.
[15]. Fakoor Z, Makooie AA, Joudi Z, Asl RG: The effect of venous caffeine on the prevention of apnea of prematurity in the very preterm infants in the neonatal intensive care unit of Shahid Motahhari Hospital, Urmia, during a year . Journal of advanced pharmaceutical technology & research 2019, 10 (1):16-19.
[16]. Iranpour R, Armanian AM, Miladi N, Feizi A: Effect of Prophylactic Caffeine on Noninvasive Respiratory Support in Preterm Neonates Weighing 1250-2000 g: A Randomized Controlled Trial .Archives of Iranian medicine 2022, 25 (2):98-104.
[17]. Hua K, Zhankui L, Jinzhen G. Effect of preventive use of caffeine citrate on premature infants’ primary apnea and related complications [J]. Chinese Journal of Child Health . 2018,26(08):882-885.(In Chinese)
[18]. Kou C, Han D, Li Z, Wu W, Liu Z, Zhang Y, Gao Z:Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea .Minerva pediatrica 2020, 72 (2):95-100.
[19]. Ying Z, Jun Z, Xiuying T, et al. Effect of caffeine on prevention of apnea in premature infants with small gestational age[J]. Tianjin Medicine 2017,45(05):518-521. (In Chinese)
[20]. Zichong Z, Qi J, Meifang L, et al. Clinical study on prevention and treatment of apnea in very low birth weight infants with caffeine citrate at different times [J]. Chinese Journal of Child Health Care 2017,25(12):1284-1287. (In Chinese)
[21]. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U et al :European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update . Neonatology 2019,115 (4):432-450.
[22]. Levitt GA, Mushin A, Bellman S, Harvey DR: Outcome of preterm infants who suffered neonatal apnoeic attacks . Early human development 1988, 16 (2-3):235-243.
[23]. Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Herring A, Laughon MM, Carlton D, Hunt CE: Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants . The Journal of pediatrics 2014,164 (5):992-998.e993.
[24]. Lodha A, Seshia M, McMillan DD, Barrington K, Yang J, Lee SK, Shah PS: Association of early caffeine administration and neonatal outcomes in very preterm neonates . JAMA pediatrics2015, 169 (1):33-38.
[25]. Eichenwald EC: Apnea of Prematurity .Pediatrics 2016, 137 (1).
[26]. Kilicdag H, Daglioglu YK, Erdogan S, Zorludemir S:Effects of caffeine on neuronal apoptosis in neonatal hypoxic-ischemic brain injury . The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2014,27 (14):1470-1475.
[27]. Park HW, Lim G, Chung SH, Chung S, Kim KS, Kim SN:Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-Analysis . Journal of Korean medical science 2015, 30 (12):1828-1835.
[28]. Borszewska-Kornacka MK, Hożejowski R, Rutkowska M, Lauterbach R: Shifting the boundaries for early caffeine initiation in neonatal practice: Results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome . PLoS One2017, 12 (12):e0189152.
[29]. Abu-Shaweesh JM, Martin RJ: Caffeine use in the neonatal intensive care unit . Seminars in fetal & neonatal medicine 2017, 22 (5):342-347.
[30]. Geetha O, Rajadurai VS, Anand AJ, Dela Puerta R, Huey Quek B, Khoo PC, Chua MC, Agarwal P: New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks . Journal of perinatology : official journal of the California Perinatal Association 2021, 41 (8):1943-1950.
[31]. Patel RM, Leong T, Carlton DP, Vyas-Read S: Early caffeine therapy and clinical outcomes in extremely preterm infants .Journal of perinatology : official journal of the California Perinatal Association 2013, 33 (2):134-140.
[32]. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD:Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance . The American review of respiratory disease 1984,130 (5):817-821.
[33]. Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Bührer C, Endesfelder S: Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine . The European respiratory journal 2013, 41 (4):966-973.
[34]. Tiwari KK, Chu C, Couroucli X, Moorthy B, Lingappan K:Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro . Biochemical and biophysical research communications2014, 450 (4):1345-1350.
[35]. Chen J, Jin L, Chen X: Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis .BioMed research international 2018, 2018 :9061234.
[36]. Soloveychik V, Bin-Nun A, Ionchev A, Sriram S, Meadow W:Acute hemodynamic effects of caffeine administration in premature infants . Journal of perinatology : official journal of the California Perinatal Association 2009, 29 (3):205-208.
[37]. Manku MS, Horrobin DF: Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists . Lancet 1976,2 (7995):1115-1117.
[38]. Bhatt-Mehta V, Schumacher RE: The effect of ibuprofen and caffeine prophylaxis on retinopathy of prematurity . Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2021,25 (5):272.e271-272.e273.
[39]. Aranda JV, Beharry K, Valencia GB, Natarajan G, Davis J:Caffeine impact on neonatal morbidities . The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2010, 23 Suppl 3 :20-23.
[40]. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W: Long-term effects of caffeine therapy for apnea of prematurity . The New England journal of medicine 2007, 357 (19):1893-1902.
[41]. Gounaris A, Kokori P, Varchalama L, Konstandinidi K, Skouroliakou M, Alexiou N, Costalos C: Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial . Archives of disease in childhood Fetal and neonatal edition 2004, 89 (4):F297-299.
[42]. Atik A, Harding R, De Matteo R, Kondos-Devcic D, Cheong J, Doyle LW, Tolcos M: Caffeine for apnea of prematurity: Effects on the developing brain . Neurotoxicology 2017,58 :94-102.
Table 1. Characteristics of included studies.